The Effect of Mandibular Advancement With Clear Aligners on Maxillary and Mandibular Volumes
1 other identifier
interventional
55
1 country
1
Brief Summary
The aim of this study is to compare the effectiveness of two different orthodontic treatment methods used in patients with skeletal Class II malocclusion, a condition in which the lower jaw is positioned backward. Approximately 80% of Class II malocclusions are due to mandibular retrusion. Therefore, functional appliances that stimulate mandibular growth in growing individuals have been widely used in orthodontics for many years. In recent years, clear aligner systems have become increasingly popular in orthodontic practice. A mandibular advancement feature was recently integrated into these aligners, allowing for simultaneous tooth alignment and forward positioning of the lower jaw. In this study, the newly developed Mandibular Advancement Appliance (MAA), based on clear aligners, will be compared to the traditional functional appliance known as the Activator. Who Can Participate in the Study? Children with retrusive lower jaws who are in the growth and development period Individuals with no prior orthodontic treatment Patients with specific levels of dental protrusion (overjet) Those with good general health and no contraindications for CBCT imaging What Will the Treatment Process Involve? Participants will be randomly assigned to one of three groups: MAA group (clear aligners with mandibular advancement) Activator group (traditional removable appliance) Control group (no treatment, only observation) The active treatment period will last approximately 7-8 months, followed by a retention phase. All patients will be monitored regularly, and strict adherence to appliance use will be expected. How Will the Outcomes Be Assessed? Before and after the treatment period, participants will undergo cone-beam computed tomography (CBCT) scans to obtain detailed three-dimensional images of the jaws. These images will be analyzed to evaluate volumetric changes. All measurements will be performed by a trained orthodontic specialist using dedicated software. Potential Benefits for Participants: Participants will receive close clinical monitoring throughout the study period. The use of advanced imaging technologies may support the development of more effective and individualized treatment plans. Safety and Confidentiality: This study has received ethical approval and will be conducted in accordance with relevant data protection and research ethics standards. All personal data will be kept confidential. Written informed consent will be obtained from all participants and/or their legal guardians.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 29, 2025
CompletedFirst Posted
Study publicly available on registry
July 9, 2025
CompletedJuly 9, 2025
June 1, 2025
1 month
June 29, 2025
June 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in mandibular volume (mm³)
Mandibular volume change will be measured using CBCT scans analyzed via Mimics software. The MAA and Activator groups will be compared to evaluate treatment effects.
Baseline and post-treatment (~8 months)
Study Arms (3)
MAA Group
EXPERIMENTALPatients receive orthodontic treatment using clear aligners (Invisalign) with integrated mandibular advancement features (MAA). Advancement is performed in 2 mm increments every 8 weeks over \~8 months.
Activator Group
ACTIVE COMPARATORPatients receive traditional removable functional appliance therapy (Activator) for \~7 months.
Control Group
NO INTERVENTIONPatients receive no orthodontic treatment but are monitored for the same duration as the treatment groups.
Interventions
Clear aligner system with integrated buccal precision wings to posture the mandible forward. Advancement protocol: 2 mm increments every 8 weeks. Total active treatment duration: \~8.15 months, followed by retention phase. Patients instructed to wear aligners ≥20 h/day, removing only for eating and oral hygiene.
Traditional removable functional appliance fabricated on a standardized bite registration. Patients instructed to wear appliance 24 h/day except during meals and sports. Total active treatment duration: \~7.15 months, followed by retention phase.
Eligibility Criteria
You may qualify if:
- Cervical vertebral maturation (CVM) stage 2 or 3
- Bilateral full or half cusp Class II molar relationship
- Skeletal Class II relationship associated with mandibular retrognathia (ANB angle \> 4° and SNB angle \< 78°)
- Horizontal or average growth pattern (SN-GoGn ≤ 38°)
- Overjet distance between +4 mm and +8 mm; (6) Good patient compliance throughout the treatment.
You may not qualify if:
- CVM stage 5 or 6;(2) Previous orthodontic treatment;
- Presence of maxillary prognathism
- High-angle growth pattern (SN-GoGn \> 38°)
- Transverse orthodontic anomalies or facial asymmetry
- Palpation-induced tenderness or pain in the masticatory muscles
- Presence of clicking, crepitus, pain, or tenderness in the temporomandibular joint (TMJ)
- Congenital or acquired craniofacial deformities
- Poor patient compliance or oral hygiene
- Any condition that could interfere with CBCT imaging.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Batman University Faculty of Dentistry
Batman, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Dr.
Study Record Dates
First Submitted
June 29, 2025
First Posted
July 9, 2025
Study Start
May 1, 2025
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
July 9, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share